Diabetic β-Cells Can Achieve Self-Protection against Oxidative Stress through an Adaptive Up-Regulation of Their Antioxidant Defenses by Lacraz, Grégory et al.
Diabetic b-Cells Can Achieve Self-Protection against
Oxidative Stress through an Adaptive Up-Regulation of
Their Antioxidant Defenses
Gre ´gory Lacraz
1, Florence Figeac
1, Jamileh Movassat
1, Nadim Kassis
2, Josiane Coulaud
1, Anne Galinier
3,
Corinne Leloup
3, Danielle Bailbe ´
1, Franc ¸oise Homo-Delarche
1, Bernard Portha
1*
1Equipe B2PE (Biologie et Pathologie du Pancre ´as Endocrine), Unite ´ BFA (Biologie Fonctionnelle et Adaptative), Universite ´ Paris-Diderot et CNRS EAC7059, Paris, France,
2Equipe HERGE, Unite ´ BFA (Biologie Fonctionnelle et Adaptative), Universite ´ Paris-Diderot et CNRS EAC7059, Paris, France, 3UMR 5241, CNRS and Universite ´ P. Sabatier,
CHU Rangueil, Toulouse, France
Abstract
Background: Oxidative stress (OS), through excessive and/or chronic reactive oxygen species (ROS), is a mediator of
diabetes-related damages in various tissues including pancreatic b-cells. Here, we have evaluated islet OS status and b-cell
response to ROS using the GK/Par rat as a model of type 2 diabetes.
Methodology/Principal Findings: Localization of OS markers was performed on whole pancreases. Using islets isolated
from 7-day-old or 2.5-month-old male GK/Par and Wistar control rats, 1) gene expression was analyzed by qRT-PCR; 2)
insulin secretion rate was measured; 3) ROS accumulation and mitochondrial polarization were assessed by fluorescence
methods; 4) antioxidant contents were quantified by HPLC. After diabetes onset, OS markers targeted mostly peri-islet
vascular and inflammatory areas, and not islet cells. GK/Par islets revealed in fact protected against OS, because they
maintained basal ROS accumulation similar or even lower than Wistar islets. Remarkably, GK/Par insulin secretion also
exhibited strong resistance to the toxic effect of exogenous H2O2 or endogenous ROS exposure. Such adaptation was
associated to both high glutathione content and overexpression (mRNA and/or protein levels) of a large set of genes
encoding antioxidant proteins as well as UCP2. Finally, we showed that such a phenotype was not innate but spontaneously
acquired after diabetes onset, as the result of an adaptive response to the diabetic environment.
Conclusions: The GK/Par model illustrates the effectiveness of adaptive response to OS by b-cells to achieve self-tolerance.
It remains to be determined to what extend such islet antioxidant defenses upregulation might contribute to GK/Par b-cell
secretory dysfunction.
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Introduction
Oxidative stress (OS) is a well-established mediator of hyperglycemic
damage to a wide range of tissues, i.e., neurons, retinal cells and
vascular endothelium [1]. Because of their high aerobic glucose
metabolismrates,pancreaticb-cells haveso farbeen considered victims
of this hyperglycemia-induced reactive oxygen species (ROS) scenario
[2], even more than other cell types, as they were reported to express
low levels of some classical ROS-scavenging enzyme systems [3,4].
In human type 2 diabetes, the concept that b-cell dysfunction
reflects OS is supported by the following findings: nitrotyrosine
and 8-hydroxy-29-deoxyguanosine (8-OHdG) concentrations are
significantly higher in diabetic than control islets and associated
with impaired glucose-stimulated insulin secretion (GSIS) [5]; OS-
related DNA damage is enhanced [6] and NADPH-oxidase is
overexpressed [7] in diabetic pancreases; in vitro 24 h exposure of
diabetic islets to the antioxidant glutathione decreases the
nitrotyrosine concentration [5], suggesting that lowering islet OS
might be a potential therapeutic approach to type 2 diabetes.
However, the notion that OS is pro-diabetic is not so straightfor-
ward, as evidence from transgene-expressing nonobese diabetic mice
studies suggests that antioxidant enzymes e.g., metallothionein and
catalase, accelerate spontaneous diabetes [8], highlighting the benefi-
cial role of ROS. Moreover, growing evidence indicates that ROS are
involved in signaling normal b-cell–glucose responsiveness [9–11].
Hence, to what extent the b-cell is able to react to enhanced and chro-
nic ROS as encountered during type 2 diabetes, remains unknown.
The Goto–Kakizaki/Paris line (GK/Par) of the spontaneous rat
type 2 diabetes model is characterized by hyperglycemia and
defective GSIS [12]. Pertinently, OS markers such as 8-OHdG
and 4-hydroxy-2-nonenal (HNE) were reported high in islets from
GK rats (Japanese colony) [13]. Moreover, we previously reported
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ing protein-1 and glutathione peroxidase-1, respectively), concom-
itantly with inflammation in diabetic GK/Par islets [14].
This study was designed to evaluate tissue localization of OS
markers and the extent to which OS contributes to b-cell injury in
GK/Par rats, by exploring the functional susceptibility of diabetic
b-cells (insulin secretion) to calibrated ROS exposure, intracellular
mechanisms of their adaptation to OS, and time-course of this OS
adaptation (taking advantage of GK/Par rat normoglycemia until
weaning).
Results
OS markers in diabetic GK/Par rats
ImmunohistochemistryondiabeticGK/Parpancreases(Fig.1)
showed, unlike Wistar, the presence of nitrotyrosine and HNE
labelling, which identify ROS and lipid peroxidation, respec-
tively. Marker-positive cells were predominantly localized at the
GK/Par islet periphery or along ducts and accompanied
inflammatory infiltrates. Such markers were absent in seven-
day-old (D7) GK/Par and D7 Wistar pancreases (data not
shown).
The glutathione redox state was 14.2% lower (p,0.001) in
GK/Par red blood cells (RBC) than Wistar (Table 1), with
comparable glutathione in its reduced form (Eq GSH) content. In
D7 GK/Par RBC, Eq GSH content was half that of D7 Wistar
(p,0.001), for comparable glutathione redox state. Plasma a-
tocopherol was higher in D7 and adult GK/Par than age-
matched Wistar rats, indicating that the OS in GK/Par does not
result from a-tocopherol deficiency. Altogether, these data
showed that signs of overall OS in GK/Par rat developed after
diabetes onset.
Figure 1. In 2.5-month-old diabetic GK/Par pancreases, nitrotyrosine, 4-hydroxy-2-nonenal (HNE)-modified proteins and 8-
hydroxy-29-deoxyguanosine (8-OHdG) accumulate in the peri-islet vascular and inflammatory compartments. Immunolabelling of
nitrotyrosine, HNE-adducts or 8-OHdG (arrows) in pancreatic tissues of GK/Par and Wistar rats (A). An islet is encircled in each quadrant. Nitrotyrosine-
positive (arrows) material was closely associated with macrophages (CD68) and granulocytes (MCA967) at the islet periphery (B), and in the vicinity of
pancreatic ducts (C). Original magnification6250.
doi:10.1371/journal.pone.0006500.g001
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ROS effect on insulin secretion
Acute effects of different ROS-generating agents on GSIS and
KCl-stimulated insulin secretion were first evaluated in vitro.
Because GSIS by GK/Par islets had to be sufficiently high to
appreciate a negative ROS impact, we used acetylcholine (ACh) to
restore their GSIS [15]. H2O2 (50 mmol/l), streptozotocin (STZ,
1 mmol/l) or alloxan (1 mmol/l) strongly blunted GSIS by Wistar
islets, as assessed by insulin secretion AUC (DIns30–50 min: 254%,
276%, or 258%, respectively, p,0.0001), but none affected GK/
Par GSIS (Fig. 2, panels A and B). Moreover, the potent oxidant tert-
butylhydroperoxide (t-BH) suppressed GSIS by Wistar islets in a
dose-dependent manner, but not in GK/Par islets except at the
highest (200 mmol/l) only (Fig. 2C). Therefore, the GK/Par GSIS
can be overcome in the presence of elevated ROS concentration.
Given that mitochondria are key players in GSIS [16], changes
of mitochondrial hyperpolarization (DYm) in response to high
glucose were evaluated. The stimulation of Wistar islets by a
glucose change from 2.8 (G2.8) to 16.7 mmol/l (G16.7) induced a
15% decrease in rhodamine 123 (Rh123) £uorescence, demon-
strating mitochondrial membrane hyperpolarization (DYm)
(Fig. 3A). As expected, addition of carbonyl cyanide p-trifluor-
omethoxyphenylhydrazone (FCCP) rapidly depolarized the mito-
chondrial membrane to a level that was used as 100% reference
for data normalization within each group. In the presence of
50 mmol/l H2O2, the DYm was abrogated in Wistar islets (Fig. 3,
panels A and C). In GK/Par islets, the decrease in Rh123 £uores-
cence triggered by glucose was abolished (Fig. 3, panels B and C)
and not further modified by H2O2.
Finally, to exclude the possibility that our observations were
merely an artefact of the GK/Par model, we used the neonatally
streptozotocin-treated rat (n-STZ) rat, another type 2 diabetes
model [17]. The n-STZ islet secretory responses to ROS were
similar to those of GK/Par islets (Fig. 4).
More AOD in diabetic GK/Par islets
The expression of a large set of antioxidant genes involved in
ROS detoxification was assessed (Fig. 5, panels A and B). The
mRNA levels of cytosolic (Sod1) and mitochondrial (Sod2)
superoxide dismutases, which represent the first-line defense
against superoxide anion generated by the mitochondrial electron
transfer chain (ETC), were overexpressed (62.3, p,0.0001; and
61.7, p,0.001, respectively) in GK/Par islets. Similarly, mRNA
accumulation was increased for antioxidant enzymes involved in
further reduction of superoxide-derived compounds (H2O2), i.e.,
catalase (Cat: 61.7, p,0.001), glutathione peroxidase-1 (Gpx1:
63.8, p,0.0001), and enzymes such as thiol/disulfide oxidore-
ductases, glutaredoxin (Glrx1) (62.2, p,0.001) and thioredoxins
(Txn162, p,0.001; and Txn261.2, p,0.05). The expression of
thioredoxin reductase (Txnrd1), necessary for NADPH-dependent
reduction of thioredoxins, was also upregulated (61.4, p,0.01).
Peroxiredoxins that catalyze H2O2 reduction to water using
thioredoxins or glutaredoxins as physiological hydrogen donors,
were also overexpressed (Prxd1: 62.6, p,0.0001; and Prxd2:
61.4, p,0.05). Finally, the abundance of GSH, the parameter
most accurately reflecting the AOD potential, was 19% greater
(p,0.01) in GK/Par islets (Fig. 5C), and was associated with more
c-glutamylcysteine ligase catalytic subunit (Gclc: 62, p,0.0001)
but less glutathione reductase (Gsr: 60.47, p,0.01) mRNAs.
Because glutathione reductase regenerates GSH from oxidized
glutathione (GSSG), improved redox balance in diabetic GK/Par
islets would make this transcript less necessary.
Because NADPH is a major substrate for GSH, thioredoxin and
glutaredoxin regeneration, the expression of genes driving
NADPH generation were assessed. GK/Par mRNA levels for
glucose-6-phosphate dehydrogenase (G6Pdx), malic enzyme-1
(Me1) and isocitrate dehydrogenase-1 (Idh1) were twice Wistar
levels (p,0.001), while nicotinamide nucleotide transhydrogenase
(Nnt) levels were comparable (Fig. 5B). Thus, NADPH production
might be enhanced in GK/Par islets. The gene encoding heme
oxygenase-1 (Hmox1), an antioxidant induced by supraphysiolog-
ical glucose concentrations [18–20], was 25-fold overexpressed
(p,0.0001), with no difference in non-inducible Hmox2 (Fig. 5A).
The transcription factor NF-E2–related factor 2 (Nrf2), which
drives the expression of many above-mentioned genes [21,22], was
also overexpressed (63.3, p,0.0001) in GK/Par islets. The
mRNA levels correlated with a strong increase of the islet NRF2
and HO-1 protein expression as measured by immunoblot (63
and 64.5, respectively, p,0.05) (Fig. 6). Moreover, the protein
level of glutathione S-transferase was also higher in these islets
(GST: 64.2, p,0.05). GST catalyses the conjugation of GSH to
electrophilic centers on a wide variety of substrates and detoxifies
endogenous compounds such as peroxidized lipids [23]. Finally
the expression of uncoupling protein-2 (Ucp2: 61.9, p,0.0001),
which limits superoxide production by dissipating the proton
gradient [24], was also increased. All these data strongly suggest
that diabetic GK/Par islets are able to protect themselves against
ROS toxicity via AOD and/or uncoupling, contrarily to naive
Wistar islets.
Less ROS accumulation in diabetic GK/Par islets
GK/Par islet AOD upregulation could limit ROS content.
Therefore, islet ROS contents, as assessed by 5-(and-6)-chlor-
omethyl-29,79-dichlorodihydro£uorescein diacetate acetyl ester
(CM-H2DCFDA), were evaluated over 30 min in response to
G2.8 or G16.7. The H2O2 accumulation by GK/Par islets at G2.8
was half that of Wistar (p,0.001) (Fig. 7A). While G16.7 decreased
ROS accumulation by 65% (p,0.0001) in Wistar (strongest effect
from G5.5 to G2.8, data not shown), only a mild decrease was
observed in GK/Par islets. At G2.8, rotenone and antimycin A
(inhibitors of ETC complexes I and III, respectively) increased
ROS contents in Wistar (p,0.01) and GK/Par islets (p,0.0001) in
GK/Par than Wistar islets at both glucose concentrations,
suggesting that the low basal ROS content in GK/Par islets did
not reflect lower activity of ETC complexes. Concomitantly, these
inhibitors blunted GSIS in Wistar (255%, p,0.0001) and GK/
Par islets (248%, p,0.05) (Fig. 7B). Trolox, an H2O2-scavenging
Table 1. Biological characteristics of 7-day-old or 2.5-month-
old male Wistar and GK/Par rats.
7-day-old 2.5-month-old
Wistar GK/Par Wistar GK/Par
Body weight (g) 16.060.3 9.460.2* 384.269.7 277.268.4*
Plasma glucose (mmol/l) 7.260.1 7.060.2 5.560.1 8.460.3*
Plasma insulin (pmol/l) 440660 160610* 840640 1000680
Plasma a-tocopherol (mmol/l) 25.260.9 30.761.3* 13.560.6 22.061.1*
RBC glutathione redox state 92.260.6 91.060.5 93.561.0 80.163.1*
RBC Eq GSH content (mmol/l) 71.168.2 37.963.2* 3.960.3 3.860.3
Glucose, insulin and a-tocopherol were determined in plasma. Glutathione
redox state (% of reduced glutathione (GSH)) and GSH (Eq GSH) content were
determined in red blood cells (RBC). Data are means6SEM. Wistar, n=9–13; GK/
Par, n=7–9.*p,0.05 vs. age-matched Wistar group.
doi:10.1371/journal.pone.0006500.t001
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islets (257%, p,0.05), but had no impact on GK/Par islets,
thereby illustrating the inefficacy of antioxidant supplementation
in these islets.
GSH biosynthesis inhibition restores activation of insulin
secretion by low H2O2 level in diabetic GK/Par islets
Physiological ROS levels were recently shown to positively
signal insulin secretion [9,11]. Here, we confirmed this mechanism
in Wistar islets, as 5 mmol/l H2O2 significantly increased (50%,
p,0.05) their insulin secretion at G2.8 (Fig. 8A). By contrast, the
ROS-signaling effect was absent in GK/Par islets, but was
restored (42%, p,0.05) by adding the GSH-biosynthesis inhibitor
buthionine sulfoximine (BSO) to 2 mmol/l H2O2 (Fig. 8C). The
ROS-signaling effect in Wistar b-cells was abolished by the GSH-
inducer N-acetyl-l-cysteine (NAC) (Fig. 8E vs. Fig. 8A). In G16.7,
NAC decreased GSIS (without H2O2: 238%, p,0.0001) by
Wistar but not GK/Par islets (Fig. 8F). The same respective
patterns were observed with trolox in Wistar (253%, p,0.001)
and GK/Par islets (Fig. 7B). As in the perifusion experiments,
GK/Par insulin secretion was resistant to 50 mmol/l H2O2, unlike
Wistar islets (Fig. 8B). Moreover, endogenous ROS levels triggered
by GSH depletion either induced by BSO or t-BH were less
effective in GK/Par when compared to Wistar islets (Fig. 8D and
Fig. 2C, respectively). Taken together, these results demonstrated
that excess antioxidant (notably GSH) is detrimental for insulin
Figure 2. Diabetic GK/Par b-cells are resistant to oxidative stress in vitro. Wistar or GK/Par islets were perifused with medium containing (in
mmol/l) 2.8 glucose (G2.8), 16.7 glucose+1 acetylcholine (G16.7+ACh1), G2.8, or 50 KCl (KCl50). Vehicle or oxidative agent (H2O2 50 mmol/l, or alloxan
1 mmol/l, or streptozotocin (STZ) 1 mmol/l) was added as indicated (A,B). DIns values (insulin secretion AUC) derived from panels (A) and (B)
indicated that GK/Par insulin secretion at G16.7 and KCl50 was strongly resistant to the toxic effects of all oxidative agents used, unlike Wistar. In
another set of experiments insulin secretion at G16.7+ACh1 was measured (static incubation, 30 min) in the presence of the GSH-oxidizing agent tert-
butylhydroperoxide (t-BH) at different concentration as indicated (C). Data are the means6SEM of 3–6 experiments in each group. *p,0.05 vs. age-
matched Wistar group;
+p,0.05 vs. vehicle in the same group.
doi:10.1371/journal.pone.0006500.g002
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might operate spontaneously in diabetic GK/Par islets.
AOD upregulation in GK/Par islets follows diabetes onset
To address the potentially causative role of the diabetic
environment in raising AOD, we studied D7 GK/Par islets,
because hyperglycemia starts around 1-month of age (weaning)
[12]. Since 12 of the 15 selected antioxidant genes were normally
expressed in D7 GK/Par islets (Fig. 9, panels A and B), we
concluded that the enhanced GK/Par AOD was mostly an
adaptive response to hyperglycemia-induced OS. However, genes
encoding Gsr and Gpx1 were, respectively, underexpressed
(60.12, p,0.001) and overexpressed (61.8, p,0.01) in D7 GK/
Par islets. This imbalance paralleled a tendency for a lower GK/
Par glutathione redox state (233%, p=0.06), with unchanged Eq
GSH content (Fig. 9C), and with a 5-fold increased ROS content,
regardless of glucose concentration (p,0.0001) (Fig. 9D), com-
pared with age-matched Wistar islets. In Wistar and D7 GK/Par
islets, raising glucose from 2.8 to 16.7 mmol/l similarly blunted
ROS contents (233%, p,0.05; and 232%, p,0.01, respectively)
(Fig. 9D). Moreover, at G2.8 or G16.7, ROS contents were
increased by rotenone and antimycin A (p,0.05), but inhibited by
trolox in D7 islets (p,0.05). Hence, prediabetic GK/Par islets
show elevated ROS levels; AOD upregulation comes later, after
diabetes onset.
Discussion
The results of this studyshow thatdiabetic GK/Par pancreases
accumulate markers of OS. This accumulation was most
prominent in non-endocrine peri-insular cells near GK/Par
islets, and was not observed in endocrine cells within the core of
the islets. For the first time, we demonstrated that GK/Par islet
Figure 3. Alteration in mitochondrial membrane potential (DYm) induced by glucose in GK/Par islets. Islets were loaded with rhodamine
123 (Rh123) in KRB–BSA containing G5.5 for 30 min, and the £uorescence intensity was monitored. Representative records of DYm responses by
islets from Wistar (A) or GK/Par (B) to glucose from 2.8 (G2.8) to 16.7 mmol/l (G16.7), and to carbonyl cyanide p-trifluoromethoxyphenylhydrazone
(FCCP, 4 mmol/l) that uncouples mitochondria, are shown. Vehicle or oxidative agent (H2O2,5 0mmol/l) was added as indicated. For each experiment,
the Rh123 fluorescence intensity obtained at G2.8 or G16.7 was normalized to the £uorescent intensity obtained after addition of carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP, 4 mmol/l) that uncouples mitochondria (C). Data are the means6SEM of 3–10 experiments in each group.
+p,0.05 vs. G2.8.
doi:10.1371/journal.pone.0006500.g003
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b-cells. The perifusion experiments are the same that those described in the legend to Fig. 2. Data are the means6SEM of 4–6 experiments in each
group.
doi:10.1371/journal.pone.0006500.g004
Figure 5. Antioxidant defense status was higher in diabetic GK/Par islets. The mRNA levels for genes encoding antioxidant proteins (A). The
mRNA levels for genes encoding proteins instrumental in the production of the antioxidant cofactor NADPH (B). Intra-insular reduced glutathione
GSH (Eq GSH) content was higher in GK/Par than Wistar rats (C). Data are the means6SEM of 8–16 experiments in each group. *p,0.05 vs. age-
matched Wistar group.
doi:10.1371/journal.pone.0006500.g005
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using specific antibody against transcription factor NF-E2–related factor 2 (NRF2), glutathione S-transferase (GST), and heme oxygenase-1 (HO-1).
Representative blots and proteins quantification are shown. Results are expressed as mean values6SEM for 3 independent experiments with 3–4
animals per experiment. *p,0.05 vs. age-matched Wistar group.
doi:10.1371/journal.pone.0006500.g006
Figure 7. Less reactive oxygen species (ROS) accumulated in diabetic GK/Par than Wistar islets. ROS generation was assessed as CM-
H2DCFDA fluorescence intensity (arbitrary units (AU)) normalized to total islet proteins in Wistar or GK/Par islets incubated at 2.8 (G2.8) or 16.7 mmol/l
glucose (G16.7) (static incubation, 30 min), in the presence or the absence of blockers of the electron transfer chain complexes I (rotenone, 10 mmol/l)
or III (antimycin A, 20 mmol/l), or the ROS scavenger (trolox, 1 mmol/l) (A). Insulin secretion values derived from experiments (B). Data are the
means6SEM of 5–23 experiments in each group. *p,0.05 vs. age-matched Wistar group;
+p,0.05 vs. G2.8 or G16.7 for the same group;
{p,0.05 vs.
G16.7 in the same experimental condition.
doi:10.1371/journal.pone.0006500.g007
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chronic OS, since they were able to maintain basal ROS
accumulation lower than in non-diabetic islet cells, due to
induction of AOD. It is hypothesized that such islet AOD
upregulation might contribute to GK/Par b-cell secretory
dysfunction (Fig. 10).
Enhanced OS within diabetic GK/Par pancreases
As in diabetic patients [2,6], GK/Par rats exhibited systemic
OS, reflected by decreased glutathione redox status in RBC.
Moreover, immunohistochemistry revealed that some non-
endocrine peri-insular cells within the GK/Par pancreases
accumulated oxidative products. While no HNE-adduct was
detectable in prediabetic D7 GK/Par pancreases, HNE labelling
was located close to vascular areas in diabetic GK/Par
pancreases, as previously described in db/db mice [25]. The
age-related accumulation of 8-OHdG and HNE-modified
proteins was reported to correlate to hyperglycemia duration in
the GK rat pancreases (Japanese colony) [13]. Macrophages and
granulocytes infiltrate around/within GK/Par islets after diabe-
tes onset [14]. Some nitrotyrosine-positive cells were found
among inflammatory infiltrates in diabetic GK/Par pancreases,
while such cells were undetectable in D7 GK/Par pancreases
(data not shown). Interestingly, similar localization within/
around islets was also described in NOD mouse [26] and type
2 diabetic humans [27], and it is known that pro-inflammatory
cytokine activities, like those of IL-1b and TNF-a,i n v o l v eR O S
generation [28].
Resistance of diabetic GK/Par islets to ROS-induced
suppression of GSIS and enhanced AOD
ecause our data indicated an OS environment surrounding
diabetic GK/Par b-cells, the acute effects of several oxidative
stressors were tested in vitro. None of them had an effect on GK/
Par GSIS, unlike Wistar. This remarkable ability to resist against
deleterious ROS entails a heightened ability to dissipate free
radical-induced stress. The effect of BSO, an inhibitor of GSH
biosynthesis, upon GSIS, was also investigated. As expected, BSO,
which lowers intra-islet GSH levels and raises endogenous islet
peroxide [29], diminished Wistar GSIS, but had no effect in GK/
Par, strongly suggesting higher AOD. Because the weak
antioxidant status of normal b-cells has been considered a major
feature of their poor resistance to oxidative injury [3,4],
stimulating AOD is currently considered the best way to
Figure 8. The dual effect (i.e., stimulatory or inhibitory) of exogenous H2O2 on insulin secretion was abolished in diabetic GK/Par
islets. The H2O2 dose-response effect on insulin secretion at 2.8 (G2.8) or 16.7 mmol/l glucose (G16.7) (static incubation, 30 min) (A,B). The same
experiments were repeated after pretreatment of islets (1 h) with the reduced glutathione (GSH)-depleting agent buthionine sulfoximine (BSO,
2 mmol/l) (C,D) or GSH-inducing agent N-acetyl-l-cysteine (NAC, 1 mmol/l) (E,F). Data are the means6SEM of 6–23 experiments in each group.
*p,0.05 vs. age-matched Wistar group;
+p,0.05 vs. H2O2 0 mmol/l in the same group;
{p,0.05 vs. BSO+H2O2 0 mmol/l in the same group.
{p,0.05 vs.
NAC+H2O2 0 mmol/l in the same group.
doi:10.1371/journal.pone.0006500.g008
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found in GK/Par islets. First, their islet glutathione was entirely in
the reduced state, this reflecting a lack of OS in the cellular
hydrophilic compartment. Second their high islet GSH level was
associated with enhanced Gclc mRNA. This is consistent with the
report that Gclc overexpression increased intra-islet GSH and
partially prevented the GSIS decrease caused by ROS generated
after islets exposure to IL-1b [28]. Once synthesized, GSH serves
as a substrate for glutathione peroxidase and GST, which destroy
H2O2, lipid peroxides and peroxinitrite [23]. Accordingly, high
Gpx1 mRNA in GK/Par islets might protect islet cells against
ROS [29] and limit nitrotyrosine (peroxinitrite-reaction product)
formation.
Concomitantly, GK/Par islets strongly express a wide battery of
crucial antioxidant genes that could contribute to the very low
GSSG level. Indeed, the best protection against ROS appears to
require combined overexpressions of genes encoding superoxide-
inactivating isoenzymes and H2O2-inactivating enzymes (Gpx1
and catalase) [30–32]. This combination was especially effective in
mouse islets because it protected mice against STZ-induced
diabetes and limited islet nitrotyrosine accumulation [33], a
pattern similar to that observed in GK/Par islets. Genes encoding
for thioredoxin metabolism-related proteins and Hmox1, known
to be induced in b-cells during OS [18,19,22,35–37] and
protective under stressful conditions [36,37], might also be at
work in GK/Par islets. Finally, globally enhanced AOD in GK/
Figure 9. Antioxidant defense status tended to be lower in prediabetic GK/Par rat islets and was associated with enhanced
reactive oxygen (ROS) production. Protocols (see the legend toFig. 5) were repeated with 7-day-old (D7) Wistar or D7GK/Par rats. The mRNA
levels for genes encoding antioxidant proteins (A). The mRNA levels for genes encoding proteins instrumental in the production of the
antioxidant cofactor NADPH (B). Intra-insular reduced glutathione (Eq GSH)content tended to be decreased in D7 GK/Par rats (C). ROS generation
was assessed as fluorescence intensity (AU) normalized by total islet proteins in D7 Wistar or D7 GK/Par islets incubated for 30 min at 2.8 (G2.8) or
16.7 mmol/l glucose (G16.7), in the presence or the absence of blockers of the electron transfer chain complexes I (rotenone, 10 mmol/l) or III
(antimycin A, 20 mmol/l), or the H2O2 scavenger (trolox, 1 mmol/l) (D). Data are the means6SEM of 10–28 experiments (n=15–51 animals) in
each group. *p,0.05 vs. age-matched Wistar group;
+p,0.05 vs. G2.8 or G16.7 in the same group;
{p,0.05 vs. G16.7 in the same experimental
condition.
doi:10.1371/journal.pone.0006500.g009
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player in the regulation of genes encoding NADPH-generating
enzymes and antioxidant response genes encoding Gclc, Trx,
Hmox1 and Gst [21,22].
Decreased GSIS and adaptive AOD in diabetic GK/Par
islets
It is generally thought that the pathway activating insulin
secretion sharply enhances endogenous ROS production, and
high glucose stimulation concurs with elevated ROS production in
several b-cell/islet models [9,29,38]. By contrast, we, like Martens
et al. [39], found that increasing glucose to 16.7 mmol/l did not
raise ROS contents in Wistar islets, but rather decreased them.
The contrast between these observations and data indicating the
primary role of ROS generation in chronic hyperglycemia-
associated b-cell dysfunction/death is intriguing and remains
unexplained. Our data clearly showed that endogenous ROS
accumulation in diabetic GK/Par islets was lower than in
prediabetic islets and it remained unchanged in response to acute
high glucose. Suppression of b-cell mitochondrial ROS formation
could potentially be contributory: however, this possibility is
unlikely because our data show an increased ROS accumulation in
the presence of mitochondrial complex blockers in diabetic GK/
Par as well as in normal islets. High rates of glucose metabolism do
not increase but prevent ROS accumulation in primary b-cells, an
effect that is more pronounced in b-cells with a higher metabolic
Figure 10. Hypothetical sketch for diabetic GK/Par b-cell adaptive protection against reactive oxygen species (ROS). (A) At low
glucose (G2.8) in the Wistar b-cell, moderate proton (H
+) accumulation outside the mitochondrial matrix, which will be passed down the electron
transfer chain (ETC) [1], and moderate electrogenic potential (DYm) [2], result from low insulin (ATP) demand [3]. (B) In the GK/Par b-cell, ROS
accumulation is lower because of: i) uncoupling protein-2 (UCP2), which dissipates DYm [4] and may be activated by FFA; and ii) antioxidant defense
systems (AOD) in mitochondria and cytosol [5], both of which guarantee b-cell self-protection against oxidative damage. (C) At high glucose (G16.7)
in the Wistar b-cell, glycolytic flux is elevated, resulting in the accumulation of H
+, and acceleration of electron transport [6]. As a result, the DYm rises
up to a point where its electrogenic potential tends to overcome the driving force of respiration-driven proton pumps (hyperpolarization) [7]: at this
stage, ETC slows down, electrons accumulate, and more ‘‘random’’ single electron transfer reactions from ETC components to molecular oxygen
enhance ROS generation. However, high glucose metabolism, through elevated NAD(P)H generation [8], improves the ROS-scavenging potential,
resulting in low ROS accumulation. (D) In the GK/Par b-cell, ROS accumulation remains low due to UCP2 [9], AOD [10] and NAD(P)H [11]. As a
consequence however, heightened AOD and/or mitochondrial uncoupling might directly weaken the GK/Par b-cell secretory function when exposed
to high glucose because of insufficient ATP generation [12].
doi:10.1371/journal.pone.0006500.g010
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trations lead to a sustained ROS production in b-cells [40].
Because modestly decreased, normal or even slightly increased
glycolytic and mitochondrial glucose oxidation rates have been
reported in diabetic GK/Par rats [41–44], and as we found
normal glucose oxidation rate in GK/Par islets in parallel
experiments (Fradet, unpublished data), it seems improbable that
decreased ROS accumulation relies on major changes in glucose
sensing and metabolism. The most likely mechanism by which
ROS production is blunted in diabetic GK/Par islets is via their
raised AOD (Fig. 10).
The relationship between the ROS-induced increase of b-cell
AOD and the impaired insulin secretion is questionable since
increased b-cell ROS production could lead to glucose-sensor
(glucokinase) inhibition [45] or suppression of glyceraldehyde-3-
phosphate dehydrogenase activity [46], with impaired GSIS in
both cases. These options do not apply in fact to GK/Par islets,
because their glucose-activated glycolytic flux was normal or
enhanced [41, 42, Fradet, unpublished data]. A more attractive
hypothesis would be that defective GK/Par GSIS results from
mitochondrial uncoupling [47]. That concept is supported by our
findings of Ucp2 overexpression and lack of DYm change in
response to high glucose, along with the reported lower ATP/ADP
ratio in GK/Par islets [48]. This hypothesis is also consistent with
the established uncoupling-dependent mechanism of protection
against OS as being responsible for diminished ATP production,
leading to impaired GSIS [20,45,49,50] (Fig. 10). Finally, our
observation that ROS sensing can be obtained when GK/Par
islets are challenged, with low H2O2 concentrations in the
presence of BSO (as are the Wistar islets in the absence of
BSO), also supports the notion that the enhanced AOD are
detrimental for insulin secretion.
Adaptive increase of AOD and chronic diabetic
environment in GK/Par islets
As previously mentioned, after diabetes onset in GK/Par rats,
b-cells are exposed in vivo to chronic inflammation and therefore to
a complex combination of ROS/NO/cytokines [51,52], first at
the islet periphery before progressing into the islets [14]. We
hypothesize that type 2 diabetic islet inflammation in GK/Par rats
might have originated from endothelial cell (EC) activation [53].
While hyperglycemia itself is well recognized to be deleterious for
EC, other factors, such as hyperlipidemia and insulin resistance,
which can precede hyperglycemia, might also be able to mediate
EC in GK/Par islets [1,52]. Also nitrotyrosine-/HNE-modified
protein accumulation in peri-islet structures, inducible NO
synthase overexpression, together with nuclear factor-kappa B
subunit p65 transactivation (data not shown) and overexpression of
various stress genes (especially Hmox1), were time-correlated with
diabetes exposure. Consistent with the GK/Par scenario, exposure
of INS-1 cells or mouse islets to HNE markedly increased AOD,
including mRNA of Nrf2-targeted genes, and depressed GSIS [9].
Moreover, chronic hyperglycemia is known to be a major cause of
islet OS, as assessed by HNE and nitrotyrosine markers in diabetic
mice [25,26]. Furthermore, islet mRNA levels of some stress/
AOD genes were enhanced by supraphysiological glucose levels in
vitro [18] or in vivo in pancreatectomized rats, but were reversed
after glycemia normalization [19,20]. The GK/Par islet model fits
well with these models of OS adaptation, as it shows upregulation
of most stress genes and antioxidant molecule (GSH) after diabetes
onset only.
However, the contribution of the prediabetic period is certainly
also crucial for adaptation. Indeed, we recently observed, in
prediabetic D7 GK/Par sera, increased FFA levels and a high
cholesterol/HDL ratio, together with elevated levels of chemo-
kines, which were probably of vascular origin [53]. In addition,
FFA-induced ROS production was at play in situations triggering
lipid overload in b-cells [54]. Taken together, an inflammatory
atherosclerotic-like reaction could explain the high levels of ROS
as well as alterations in glutathione and thioredoxin-related gene
expression in GK/Par islets at this age. It is possible that this
microangiopathy/atherosclerosis islet process might be initiated by
a dyslipidemia during the prenatal period because higher
circulating cholesterol/HDL ratio is already present in E21.5
GK/Par fetuses and would be instrumental in in utero program-
ming of islet endothelial activation/OS in the GK/Par rat [53].
Finally, the low islet functional susceptibility to ROS exposure
we found in another type 2 diabetes model, the n-STZ-treated rat,
strengthens the possibility that chronic hyperglycemia promotes b-
cell self-adaptation to OS. In conclusion, our study shows that the
possibility for eukaryotic cells to acquire tolerance to lethal ROS
doses by prior exposure to sublethal doses [55,56], is also operative
under pathological conditions such as spontaneous type 2 diabetes.
Materials and Methods
All animal experiments were conducted on age-matched male
GK/Par [12] and non-diabetic Wistar rats from our local colonies
in accordance with accepted standards of animal care, established
by the French National Center for Scientific Research (CNRS). In
some experiments, newborn Wistar received STZ to induce type 2
diabetes [17]. All pharmacological agents, except
125I-labeled
insulin (DiaSorin) and metaphosphoric acid (VWR Prolabo), were
purchased from Sigma-Aldrich.
Immunohistochemistry
For HNE and 8-OHdG labelling, Wistar and GK/Par rat
pancreases were fixed in aqueous Bouin’s solution and embedded
in paraplast, according to standard procedures. For nitrotyrosine
labelling, pancreases were frozen in n-hexane on dry ice-chilled
alcohol [14]. Immunohistochemistry used: 1) rabbit anti-mouse
nitrotyrosine (Upstate) and anti-Ig horseradish peroxidase detec-
tion kit (BD Pharmingen) according to the manufacturers’
instructions; 2) mouse anti-HNE or 3) mouse anti-8-OHdG (the
last two antibodies from Japan Institute for the Control Aging), the
secondary antibody (biotin-conjugated rabbit F(ab9)2 anti-mouse
IgG, Serotec), and the Vectastin Universal ABC-AP kit (Vector),
followed by the Vector Black substrate kit. CD68 and MCA967
labellings were done as described by the manufacturer.
Islet isolation
D7 or non-fed (post-absorbtive state) 2.5-month-old adult rats
were killed by decapitation and pancreatic islets were isolated in
collagenase (Sigma) and then handpicked under a stereomicro-
scope [15].
Insulin secretion
Freshly isolated islets were perifused as previously described [15]
and exposed to G2.8 or G16.7 or KCl 50 mmol/l (KCl50), in the
absence or presence of oxidant (50 mmol/l H2O2, or 1 mmol/l
STZ, or 1 mmol/l alloxan) for times indicated. For static
incubations, batches of 10, or 20, or 50 freshly isolated islets were
preincubated with 1 mmol/l NAC or 2 mmol/l BSO for 1 h at
37uC in 1 ml Krebs–Ringer bicarbonate (KRB)–BSA containing
5.5 mmol/l glucose (G5.5). After washing, pretreated islets were
stimulated for 30 min at 37uC in 1 ml KRB–BSA containing G2.8
or G16.7 alone or supplemented with H2O2 or t-BH at different
concentrations. A radioimmunoassay determined insulin secretion.
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Rh123 (Invitrogen) fluorescence (excitation: 488 nm; emission:
530 nm)wasused as an indicator of DYm as described [10,57]. This
£uorescent lipophilic cationic dye is known to be specifically
partitioned into negatively charged mitochondrial membranes. In
cells preloaded with Rh123, when DYm increases (hyperpolariza-
tion) as seen after nutrient stimulation, more Rh123 is concentrated
into the mitochondrial membrane, leading to an aggregation of dye
moleculesandquenchingofthe ;£uorescence signal.Depolarization
of DYm, on the other hand, allows dye to redistribute from
mitochondria into the cytosol, resulting in an increase of the Rh123
signal. In the present study, intact islets were loaded with Rh123
(10 mg/ml) for the last 20 min of a 1-h preincubation in KRB–BSA
containing G5.5. Then, 10 islets were perifused on the stage of an
inverted fluorescent microscope (Nikon Diaphot). After background
subtraction, the £uorescence emitted from each islet was normal-
ized to the £uorescence level measured after addition of FCCP
(4 mmol/l) that uncouples mitochondria.
ROS measurements
Islets were loaded with the fluorescent probe CM-H2DCFDA
(4 mmol/l) (Invitrogen) for 30 min at 37uC [10] and then rapidly
frozen and stored at 280uC. Supernatant ROS content (200 ml)
was quantified with a reader (Fluostar Galaxy, BMG; excitation:
485 nm; emission: 530 nm).
mRNA analysis
Total RNA was isolated from islets using the RNeasy mini kit
(Qiagen) and its concentration determined by optical density at
260 nm. To remove residual DNA contamination, the RNA
samples were treated with RNase-free DNAse (Qiagen) and
purified with RNeasy mini-column (Qiagen). Total RNA (4 mg)
from each islet sample was reverse transcribed with 40 U of M-
MLV Reverse Transcriptase (Invitrogen) using random hexamer
primers. The primers used were derived from rat sequences and
designed using OLIGO6. Real-time quantitative PCR amplifica-
tion reactions were carried out in a LightCycler 1.5 detection
system (Roche) using the LightCycler FastStart DNA Master plus
SYBR Green I kit (Roche). Reverse transcribed RNA (10 ng) was
used as the template for each reaction. All reactions were run in
duplicate with no template control. The PCR conditions were:
95uC for 10 min, followed by 40 cycles at 95uC for 10 s, 60uC for
10 s and 72uC for 10 s. mRNA transcript levels of 4 housekeeping
genes (rpL19, Tbp, cyclophilin a, 18S) were assayed; rpL19 was
retained for normalization of other transcripts.
Western blot analysis
Western blot analysis was performed as previously described
[58] to study NRF2, or GST, or HO-1 protein expression. Briefly,
25 mg (for GST and HO-1) or 50 mg (for NRF2) of proteins
extracted from GK/Par or Wistar islets were subjected to SDS-
PAGE (10% acrylamide gel) and then transferred to a PVDF
membrane for 2 h (120 V) using a Bio-Rad Mini Trans Blot
electrophoretic transfer unit (Bio-Rad). The membranes were
blocked for nonspecific binding with 5% non fat dry milk in Tris-
buffered saline (TBS, 20 mM Tris-HCl, 150 mM NaCl, pH 7.4)
supplemented with 0.05% Tween 20 (TTBS) and then probed
with the specific primary antibodies. After 3 washes with TTBS,
membranes were incubated with appropriate horseradish perox-
idase-conjugated secondary antibodies. Separated proteins were
visualized by an ECL kit (GE Healthcare) and light emission was
captured on X-ray film (GE Healthcare). Intensities of the
respective bands were examined by densitometric analysis (Scion
Image Analyst program).
Glutathione and a-tocopherol measurements
To measure glutathione, RBC (50 ml) were mixed with 1%
EDTA/5% metaphosphoric acid (1:5 v/v; 450 ml), and 100 or 200
islets were mixed with 5% metaphosphoric acid (300 ml). After
centrifugation (3000 g, 10 min, 4uC), GSH and GSSG were
identified in supernatants by reverse-phase HPLC with electro-
chemical detection [59]. Results are expressed as mmol/l of RBC
or mmol/g of islet proteins. Total glutathione content, referred to
as ‘‘equivalent GSH’’ (Eq GSH), is the sum of GSH and doubled
GSSG concentrations (2GSHRGSSG). The glutathione redox
state is: ([reduced form]/[total forms])6100, with [total for-
ms]=[oxidized form]+[reduced form]. a-Tocopherol was deter-
mined, as above, in heparinated plasma (100 ml) extracted with 2-
propanol (400 ml) [60]. Results are expressed as mmol of plasma.
Data presentation and statistical analysis
Variations of DYm are presented as fluorescence changes over
the basal level (G2.8). Integrated elevation above baseline value
(DIns (AUC for insulin secretion), in ng/10 islets) was used to
quantitate insulin response. Data are presented as means6SEM.
Statistical analyses used an unpaired Student’s t test or ANOVA as
appropriate. Significance was defined as p,0.05.
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